Patients with new-onset alopecia areata are at increased 10-year risk of developing several immune-mediated inflammatory diseases, according to a study.

RNA-based medicine is about to take a huge leap forward thanks to the discovery of extremely short RNA fragments with important anti-inflammatory properties. Professor Michael Gantier's latest ...

As the first CAR-T treatment for an autoimmune disease draws ever closer, officials at the FDA have signaled a willingness to support the development of these novel cell therapies with a flexible ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

DEAR DR. ROACH: My 28-year-old son is in the hospital. He hasn’t been acting like himself for a few weeks (not sleeping nor eating well), and he suddenly had four seizures. The doctors are worried ...

CAR T-cell therapies are now being used to treat patients with B-cell driven autoimmune diseases such as lupus. Another such condition is autoimmune hemolytic anemia, in which immune cells destroy red ...

Despite common depression and anxiety diagnoses among both individuals with autoimmune hepatitis and the general population, there is no increased risk for long-term psychiatric disorders among those ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune ...

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the ...

LONDON, Jan 7 (Reuters) - GSK (GSK.L), opens new tab will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory applications, it said on ...